Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.

Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check5 days agoChange DetectedNo meaningful differences were observed between the two screenshots; the Study Details page for NCT03469960 remains the same with identical sections and information.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check41 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check55 days agoChange DetectedPage updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and multiple locations in France, while also removing various related medical topics and terms. Notably, the revision number has been updated from v2.16.12 to v3.0.0.SummaryDifference5%

Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.